← All companies

Health & Frontier Tech / COMPANY INTELLIGENCE

Neuralink

Develops implantable brain-computer interfaces and robotic surgical systems.

01 / THE BUSINESS

How Neuralink creates value.

Develops implantable brain-computer interfaces and robotic surgical systems. The research focus is whether customer adoption can support attractive economics after development, delivery and ongoing service costs.

SectorHealth & Frontier Tech
Founder coverage2 profiles
Research checkedSep 18, 2026

02 / PEOPLE BEHIND THE COMPANY

Meet the builders.

Elon Musk

Co-founder

Elon Musk

Elon Musk is a co-founder of Neuralink. The company’s founding and leadership material provides context for its work in brain-computer interfaces.

Explore founder

Co-founder

DJ Seo

DJ Seo is a co-founder of Neuralink. The company’s founding and leadership material provides context for its work in brain-computer interfaces.

Explore founder

Selected founders; historical founding roles are distinct from current management positions.

03 / CAPITAL & OWNERSHIP

Follow the financing.

Selected disclosed events, newest first. Announcement values describe that transaction and date; they are not current share prices. Debt, equity and secondary transactions are identified separately.

A financing figure is not established here.

Use the original company sources below to check new announcements. We have not substituted an estimate for a disclosed round.

04 / IN THEIR OWN WORDS

Watch. Listen. Form your view.

Lex Fridman Podcast · 2024-08-02

Elon Musk & the Neuralink team

A discussion with the founder and team about brain-computer interfaces and the company’s work.

Watch on YouTube

Interviews reflect the speaker’s perspective at publication. Company statements are not independent verification.

05 / EDITORIAL ANALYSIS

The opportunity. The open questions.

Our interpretation of the business model and cited sources, not a valuation or a recommendation.

What could work

The case to investigate

  • Human clinical progress and the potential platform value of high-bandwidth neural interfaces.
  • A stronger product position becomes economically meaningful when customers renew, expand and pay enough to cover delivery costs.
What could go wrong

Pressure-test the thesis

  • Patient safety.
  • Regulatory uncertainty.
  • Long product timelines.

What to watch next

01

Clinical outcomes — what changed in the latest original disclosure?

02

Regulatory milestones — what changed in the latest original disclosure?

03

Device reliability — what changed in the latest original disclosure?

YOUR RESEARCH WORKSPACE

Keep the questions that matter.

Use this checklist to record what you have investigated. Your notes stay in this browser.

06 / RESEARCH TRAIL

Go straight to the source.

Research checked Sep 18, 2026. Selected public disclosures, not a complete capitalization table or securities-filing search. Missing information is left unconfirmed. No investment availability or IPO date is implied.